Structural Determinants of Youth Drug Use. Spooner C, Hall W and Lynskey M (2001)

Structural Determinants of Youth Drug Use. Spooner C, Hall W and Lynskey M (2001) This report was commissioned by the Aus- tralian National Council on Drugs and summarises the available literature on the structural determinants of youth drug use. The breadth of information that could potentially be incorporated in this report is enormous, including literature from the fields of health (public health, child and adolescent development, mental health), economics, crime prevention, social policy and town planning.

Download this publication

The Asian Harm Reduction Network: Supporting Responses to HIV and Injecting Drug Use in Asia. UNAIDS (2001)

The Asian Harm Reduction Network: Supporting Responses to HIV and Injecting Drug Use in Asia. UNAIDS (2001) In the past two decades, many countries in the Asian region have witnessed dramatic changes in drug-use patterns, with more individuals switching from smoking to injecting. These changes have resulted in the deterioration of the health status of drug users. Newer and more potent forms of drugs have flooded the Asian markets, and there has been a rapid increase in the numbers of drug users all across Asia. Legal and social impediments to needle and syringe availability have caused users to inject with inappropriate equipment in unhygienic circumstances. We have begun to see ugly wounds and abscesses among the injecting drug users (IDUs) and a rapid increase in the numbers of drug users infected with hepatitis B/C and HIV.

Download this publication

A Comprehensive Approach: Preventing Blood-Borne Infections among Infection Drug Users. Academy for Educational Development (2000)

A Comprehensive Approach: Preventing Blood-Borne Infections among Infection Drug Users. Academy for Educational Development (2000) Since 1981, 733,374 cases of AIDS have been reported to the Centers for Disease Control and Prevention (CDC). In 1999, 46,400 new cases were reported. It is estimated that 650,000 to 900,000 Americans are now living with HIV, and that approximately 40,000 new infections occur each year.

Download this publication

Drug Use and HIV Vulnerability Policy Research Study in Asia. UNAIDS and UNODCCP (2000)

Drug Use and HIV Vulnerability Policy Research Study in Asia. UNAIDS and UNODCCP (2000) In many of the study-countries minor modifications to the drug control legisla- tion are necessary in order to implement more effective HIV/AIDS prevention among drug users. High-risk behaviours are commonplace among drug users in all the study- countries and there is an observable trend of multiple drug use. In general, drug policies in the study-countries are not supportive of effective HIV prevention among drug users. With the exception of law enforcement, drug problems are not generally accorded high funding priority.

Download this publication

Drug Use and HIV/AIDS in Thailand in the Year 2000. Asian Harm Reduction Network, FHI, Impact, et al (2000)

Drug Use and HIV/AIDS in Thailand in the Year 2000. USAID, FHI, Impact, et al (2000) In Thailand, estimates indicate that 984,000 persons have been infected since 1988 with HIV and that approximately 289,000 people have died of AIDS. Over 695,000 persons are now living with HIV. At the end of 1999, national HIV sentinel surveillance showed that prevalence had declined among Army conscripts, female direct/indirect sex workers, and pregnant women, but had increased among injecting drug users, from 39% in 1989 to 54.1% by June 1999.

Download this publication

Baseline Study of the Relationship between IDU, HIV and Hepatitis C among Male IDUs in Lahore. UNODCCP and UNAIDS (1999)

Baseline Study of the Relationship between IDU, HIV and Hepatitis C among Male IDUs in Lahore. UNODCCP and UNAIDS (1999) A baseline study of injecting drug users (IDUs) in Lahore, undertaken in January and February, 1999, by UNDCP and UNAIDS, revealed an alarmingly high rate of infection by hepatitis C virus (HCV) among the study population. The study results suggest the potential for an even greater public health challenge in the form of an epidemic of human immunodeficiency virus (HIV) once the virus enters this highly vulnerable population. In addition, there is the possibility of a more generalised HIV epidemic as a result of secondary transmission through sexual activity. The study results will have important implications for the formulation of Pakistan's strategies regarding drug abuse, especially among IDUs, and for the development of appropriate and effective plans for programmes of HIV/AIDS awareness and prevention.

Download this publication

Nepal HIV Drug Assessment Report. UNAIDS (1999)

Nepal HIV Drug Assessment Report. UNAIDS (1999) Nepal UNAIDS-APICT - Research on the Relationship between Drug Use, Drug Policy & HIV/AIDS Vulnerability

Download this publication

Myanmar Opium HIV. Soeparna S.

immage

Infographic on Myanmar Opium HIV by Safir Soeparna, WE CAN BEAT HIV

 

Keywords: HIV, AIDS, IDU, needles, injection

 

 

 

 

 

 

 

 

Download Infographic

Treatment Access for Injecting Drug Users (IDUs) Living with HIV in Asia. APN+ (no date)

Treatment Access_for_IDU_Living_with_HIV_in_Asia

Factors such as stigma and discrimination, poverty, criminalization of drug use, sex work and homosexuality, limited antiretroviral therapy (ART) service facilities and lack of trained healthcare professionals on HIV treatment have all been cited as barriers to HIV treatment access for people living with HIV (PLHIV).

 

 

Download this publication

Pages

database
Highlighted publications
http://aidsdatahub.org/sites/default/files/highlight-reference/document/Nepal-IBBS-FIDU-Kathmandu-valley-RI-2016.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_Get_on_the_Fast-Track_2016.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/NEC_HIV_July-Oct-AIDSreg2016.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_methods_for_deriving_estimates_2016.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_Global_AIDS_Response_Progress_Reporting_2016.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/2015_Size_Estimation_of_Key_Affected_Populations_in_Philippines.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/Assessment_of_Decentralization_of_ART_in_MMR_2016.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS-2016-prevention-gap-report_en.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_AIDS_by_the_numbers_2016.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_Biomedical_AIDS_research_2016.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/Implementing_comprehensive_HIV_and_STI_programmes_with_transgender_people_2016.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_cities_ending_the_aids_epidemic_2016.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/Philippines_2015_IHBSS_Factsheets.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/Pakistan_IBBS_Report_Punjab_2014_0.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Integrating_collaborative_TB_and_HIV_services_within_a_comprehensive_package_of_care_for_PWID_2016.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/India_IBBS_report_2014-15.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/India_HSS_report_2014-15.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/The_negative_impact_of_drug_control_on_public_health_2015.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/2015_young_people_drugs_en.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/Death_Penalty_for_Drug_Offences_Global_Overview_2015.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/Transforming_our_world_2015_UN.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Consolidated_on_the_use_of_antiretroviral_drugs_for_treating_and_preventing_HIV_infection_2016.pdf
http://aidsdatahub.org/sites/default/files/highlight-reference/document/Consolidated_Strategic_Information_Guidelines_for_HIV_in_Health_Sector_2015.pdf
Calendar of events
Mar
24
(24 Mar - 24 Mar)
Apr
7
(7 Apr - 7 Apr)
May
17
(17 May - 17 May)